TABLE 4.
Ambler class type | Antimicrobial agent | MIC range (μg/ml) | MIC50 (μg/ml) | MIC90 (μg/ml) |
---|---|---|---|---|
A-ESBLb | CTB | 0.12 to ≥64 | 8 | ≥64 |
CTB/VNRX-5236 | 0.03–1 | 0.12 | 0.25 | |
CTB/CLA | 0.03 to ≥64 | 0.12 | 0.5 | |
AMC | 8 to ≥64 | 16 | 32 | |
Sulopenem | 0.03–1 | 0.12 | 0.5 | |
Tebipenem | ≤0.016–0.12 | 0.03 | 0.06 | |
A-KPCc | CTB | 0.5 to ≥64 | 16 | ≥64 |
CTB/VNRX-5236 | 0.06–1 | 0.12 | 1 | |
CTB/CLA | 0.25 to ≥64 | 8 | ≥64 | |
AMC | 32 to ≥256 | ≥64 | ≥256 | |
Sulopenem | 4 to ≥64 | 32 | ≥64 | |
Tebipenem | 8 to ≥64 | ≥64 | ≥64 | |
Cd | CTB | 2 to ≥64 | 16 | ≥64 |
CTB/VNRX-5236 | 0.03–2 | 0.12 | 1 | |
CTB/CLA | 0.06 to ≥64 | 2 | ≥64 | |
AMC | 8 to ≥256 | 32 | ≥256 | |
Sulopenem | 0.03–8 | 0.06 | 2 | |
Tebipenem | ≤0.016–2 | 0.06 | 0.5 | |
De | CTB | 0.06 to ≥64 | 16 | ≥64 |
CTB/VNRX-5236 | 0.03–2 | 0.12 | 1 | |
CTB/CLA | 0.06 to ≥64 | 4 | 32 | |
AMC | 128 to ≥256 | ≥256 | ≥256 | |
Sulopenem | 1 to ≥64 | 8 | 16 | |
Tebipenem | 0.5 to ≥64 | 4 | 16 |
CTB, ceftibuten; CTB/VNRX-5236, ceftibuten with VNRX-5236 fixed at 4 μg/ml (boldface); CTB/CLA, ceftibuten with clavulanic acid fixed at 4 μg/ml; AMC, amoxicillin with clavulanic acid tested at a 2:1 ratio.
Includes 12 strains of E. coli and 13 strains of K. pneumoniae.
Includes 1 strain of E. coli, 19 strains of K. pneumoniae, 3 strains of E. cloacae, and 2 strains of Klebsiella oxytoca.
Includes 7 strains of E. coli, 7 strains of K. pneumoniae, 3 strains of Klebsiella aerogenes, 6 strains of Serratia marcescens, 1 strain of Proteus mirabilis, and 1 strain of Citrobacter freundii.
Includes 12 strain of E. coli and 13 strains of K. pneumoniae.